Hindustan Bio Sciences Share Price Today | Stock Price & Hindustan Bio Sciences Share Screener
As of October 5, 2026, the live Hindustan Bio Sciences share price (BSE: HINDBIO) is ₹7.02, down 4.49% from the previous close, with shares trading between ₹7.00 and ₹7.57 in today's trading session, and a 52-week range of ₹5.04–₹9.66. Check HINDBIO price range for the annual price range and momentum. Use the Hindustan Bio Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Hindustan Bio Sciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Hindustan Bio Sciences Share Price Chart
Track the current stock price of Hindustan Bio Sciences with an interactive chart. Analyse HINDBIO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Hindustan Bio Sciences stock quote in one place.
The quote of ₹7.02 sits between the 52-week low of ₹5.04 and the 52-week high of ₹9.66, and the latest session moved -4.49% from the previous close.
Hindustan Bio Sciences Company Profile - Fundamental Screener
Screen Hindustan Bio Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for HINDBIO shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Information Technology sector and the Software Products industry, and it trades under ISIN INE597C01021.
Company Details
Classification
Identifiers and Leadership
Hindustan Bio Sciences Balance Sheet Screener
Screen HINDBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹3, down from ₹3 in 2025.
Latest statistics put total assets at ₹3 and shareholder funds at ₹1, with a leverage ratio of 2.81.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 3 | 3 | 3 | 3 | 3 | 4 | 6 | 6 | 4 | 6 |
| Current Assets | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 1 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 3 | 3 | 1 | 1 | 1 | 2 | 3 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 4 |
| Share Capital | 2 | 2 | 2 | 2 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -1 | -1 | -1 | -1 | -10 | -9 | -8 | -8 | -8 | -6 |
Hindustan Bio Sciences Income Statement Screener - Profit & Revenue Analysis
Screen Hindustan Bio Sciences income statement and profit fundamentals. Analyze HINDBIO quarterly results. Hindustan Bio Sciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0, equal to earnings per unit of ₹-0.20, at an operating margin of 5%.
In that period expenses were ₹1, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹1 and net profit of ₹0.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 2 | 4 | 1 | 1 | 1 | 1 |
| Expenses | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 2 | 1 | 2 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 0 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 | -2 | -1 | 0 | -1 |
| Operating Profit % | 5.00% | -8.00% | 12.00% | 6.00% | -3.00% | -118.00% | -91.00% | 7.00% | 4.00% | -228.00% | -46.00% | -10.00% | -163.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 | -2 | -1 | -2 | -1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 | -2 | -1 | -2 | -2 |
| EPS | -0.20 | -0.08 | 0.10 | 0.06 | -0.04 | -0.50 | -0.92 | 0.08 | 0.11 | -2.22 | -0.48 | -2.04 | -1.42 |
Hindustan Bio Sciences Cash Flow Screener - Liquidity Fundamentals
Screen HINDBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹0.
Over the same period, investing activities provided ₹0 and financing activities provided ₹0.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 0 | 0 | -1 | 0 | 0 | 1 | 1 | -1 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing and Net Cash | ||||||||||
| Financing Activities | 0 | 0 | 1 | 0 | 0 | -1 | -1 | 2 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hindustan Bio Sciences Shareholding Pattern Screener
See Hindustan Bio Sciences shareholding pattern with promoter, FII, and DII holdings. Check Hindustan Bio Sciences promoter holding and ownership changes for HINDBIO on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 12.19%, foreign institutions 0.00%, domestic institutions 0.00% and the public 81.33%, spread across 11,707 shareholders.
The shareholder count was 11,707 in 2026-Jun, compared with 11,530 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 12.19% | 12.19% | 12.19% | 12.19% | 12.19% | 12.19% | 12.19% | 12.19% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 81.33% | 81.48% | 81.69% | 81.68% | 84.02% | 84.02% | 84.04% | 84.08% |
| Other Holding | 6.48% | 6.33% | 6.12% | 6.13% | 3.79% | 3.79% | 3.77% | 3.73% |
| Shareholder Count | 11,707 | 11,530 | 11,516 | 11,405 | 11,620 | 11,246 | 11,276 | 11,618 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Hindustan Bio Sciences. Hindustan Bio Sciences dividend yield can be compared with peers and other stocks in the market.
Hindustan Bio Sciences Stock Index Membership - Nifty & Sensex
See which indices include Hindustan Bio Sciences stock. Check HINDBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Hindustan Bio Sciences Market Events Screener - Corporate Actions
Get Hindustan Bio Sciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Hindustan Bio Sciences stock events that may affect HINDBIO share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.
It is followed by Quarterly Result Announcement dated July 31, 2026 and Quarterly Result Announcement dated May 30, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | 2.27% |
| 2026-07-31 | 2026-07-31 | Quarterly Result Announcement | NA | -3.56% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -3.41% |
| 2026-01-31 | 2026-01-31 | Quarterly Result Announcement | NA | 8.51% |
| 2025-10-31 | 2025-10-31 | Quarterly Result Announcement | NA | -15.90% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -9.55% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | -1.44% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 34.73% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -5.76% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 7.85% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 14.68% |
| 2023-12-29 | 2023-12-29 | Extraordinary General Meeting | NA | -3.07% |
Hindustan Bio Sciences Competitors Screener - Peer Stocks Comparison
Screen HINDBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Information Technology sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Oracle Financial Services Software | 91,176 | 26.59 | 7,943 | 11.07% | 2,639 | 35.01 |
| Tanla Platforms | 6,473 | 12.14 | 4,455 | 9.52% | 509 | 37.77 |
| CE Info Systems | 4,787 | 33.61 | 527 | 2.09% | 134 | 39.74 |
| Moschip Technologies | 3,820 | 143.55 | 585 | 24.29% | 33 | 36.98 |
| TechNVision Ventures | 2,398 | 766.83 | 271 | 18.27% | 0 | 33.80 |
| Ramco Systems | 2,088 | 49.50 | 708 | 18.65% | 42 | 42.14 |
| Blue Cloud Softech Solutions | 1,810 | 28.84 | 1,002 | 25.60% | 61 | 43.58 |
| Nucleus Software | 1,679 | 16.22 | 940 | 4.64% | 117 | 17.87 |
| Subex | 1,080 | 36.53 | 311 | 6.22% | 29 | 51.12 |
| Unicommerce eSolutions | 916 | 43.63 | 208 | 48.64% | 21 | 44.01 |
Hindustan Bio Sciences Company Announcements - News & Reports Screener
Screen HINDBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 1, 2026.
The next most recent announcements are dated October 1, 2026 and October 1, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-10-01 | Proceedings Of AGM | - |
| 2026-09-27 | Closure of Trading Window | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-03 | Shareholder Meeting - AGM On 30-09-2026 | - |
| 2026-09-03 | Reg. 34 (1) Annual Report. | - |
| 2026-08-31 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-08-26 | Board Meeting Intimation for To Consider The Draft Scheme Of Reorganization/Rearrangement Of Share Capital Of The Company. | - |
| 2026-08-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-31 | Results For The Quarter Ended 30Th June 2026 | - |
| 2026-07-31 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday July 31 2026 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulation 2015 | - |
| 2026-07-22 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 (1) (A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-07-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-27 | Closure of Trading Window | - |
| 2026-06-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-30 | Appointment Of Internal Auditor For The Year 2026-27 | - |
| 2026-05-30 | Audited Financial Results For The Fourth Quarter And Financial Year Ended 31St March 2026 | - |
| 2026-05-30 | Board Meeting Outcome for Approved Audited Results For The Fourth Quarter And Financial Year Ended 2026 | - |
| 2026-05-21 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹7.02, within a 52-week range of ₹5.04 to ₹9.66. The P/E ratio is -36.75 and the P/B ratio is 9.12, with earnings per unit of ₹-0.08. Market capitalisation stands at ₹7.64 Cr. The company operates in the Information Technology sector, in the Software Products industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.